• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Research Journal of Parasitology
  2. Vol 15 (2), 2020
  3. 38-46
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Research Journal of Parasitology

Year: 2020 | Volume: 15 | Issue: 2 | Page No.: 38-46

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 226

Authors


Tohada M. AL-Noshokaty

Country: Egypt

Ibrahim  Aly

Ibrahim Aly

LiveDNA: 20.18604

Dina M. Abo-Elmatty

Country: Egypt

Noha M. Mesbah

Country: Egypt

Ahmed S. Shehata

Country: Egypt

Samia Etewa

Country: Egypt

Keywords


  • Solid lipid nanoparticles
  • Schistosoma mansoni
  • curative drug
  • histopathological studies
  • liver enzymes
  • cytokine level
Research Article

Evaluation of Solid Lipid Nanoparticles Loaded with Praziquantel for Treatment of Schistosoma mansoni Infected Rats

Tohada M. AL-Noshokaty, Ibrahim Aly Ibrahim  Aly's LiveDNA, Dina M. Abo-Elmatty, Noha M. Mesbah, Ahmed S. Shehata and Samia Etewa
Background and Objectives: Solid Lipid Nanoparticles (SLN) are a promising drug delivery system for oral administration of poorly water soluble drugs. Solid Lipid Nanoparticles (SLN) are at the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery and research. The present work aimed to evaluate the efficacy of SLN loaded with praziquantel (PZQ) for treatment of schistosomiasis. Materials and Methods: The SLN was prepared and characterized to be a carrier for PZQ. Seventy male rats were divided equally into 7 groups (10 rats/group); normal control, infected control, infected and received SLN at 14 and 35 days, infected and received SLN loaded with PZQ which administered orally as two consecutive doses at days 14 and 35 post-infection, the last group infected and received PZQ. All rats were sacrificed after 8 weeks PI. Results: Liver section showed that treatment with SLN-PZQ the granuloma diameter was reduced. ALT and AST levels were decreased. Total Protein (TP) was increased and Gamma-glutamyl transferase was decreased. Level of IL-4 was decreased while, IL-10 level was high in treated group. Administration of PZQ at 35 days showed complete disappearance of ova. However, administration of SLN loaded with PZQ at 35 days post-infection decreased the worm burden and ova count in both liver and intestine compared to infected untreated group. Conclusion: Results of the present study conclude that the encapsulation of PZQ in SLN improved the safety profile of the drug. The PZQ in SLN could be a promising formulation to enhance the pharmacological activity of PZQ.
PDF Fulltext XML References Citation

How to cite this article

Tohada M. AL-Noshokaty, Ibrahim Aly, Dina M. Abo-Elmatty, Noha M. Mesbah, Ahmed S. Shehata and Samia Etewa, 2020. Evaluation of Solid Lipid Nanoparticles Loaded with Praziquantel for Treatment of Schistosoma mansoni Infected Rats. Research Journal of Parasitology, 15: 38-46.

URL: https://scialert.net/abstract/?doi=jp.2020.38.46

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved